Nov 24 (Reuters) – U.S. healthcare company Johnson & Johnson
has approached Swiss biotechnology firm Actelion Ltd
about a potential takeover, Bloomberg reported on
Thursday, citing people it said…
The post J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg appeared first on NASDAQ.